Mississippi 2025 Regular Session

Mississippi House Bill HB1463

Introduced
1/20/25  
Refer
1/20/25  
Engrossed
2/13/25  
Refer
2/17/25  
Enrolled
3/13/25  

Caption

Pseudoephedrine; require manufacturers to pay fees to National Association of Drug Diversion Investigators to support NPLE.

Companion Bills

No companion bills found.

Similar Bills

MS SB2733

NPLEx; require manufacturers of certain pseudoephedrine or ephedrine products to pay fees to support the administration of.

TX SB913

Relating to the transmission of records regarding over-the-counter sales of ephedrine, pseudoephedrine, and norpseudoephedrine and a person's civil liability for certain acts arising from the sale of those products.

TX HB1137

Relating to the transmission of records regarding over-the-counter sales of ephedrine, pseudoephedrine, and norpseudoephedrine and a person's civil liability for certain acts arising from the sale of those products.

MO SB726

Limits the sale or purchase of certain drugs

MN HF2476

Over-the-counter allergy medicine sale restrictions modified.

MN SF3087

Restrictions placed on the sale of certain over-the-counter allergy medications modifications

MS HB856

Pharmacy Practice Act; extend repealer on and make various changes to.

MS SB2795

Pharmacy Practice Act; extend repealer on and make various changes in.